MIRAPEXIN 2.62 mg prolonged-release tablets

Company
Boehringer Ingelheim Limited
Active Ingredient
Dosage Form
Prolonged-release tablet
Legal Category
B - prescription, may be renewed
Licence number Strength ATC Code Dosage Form
EU/1/97/051/031 2.62 milligram(s) N04BC05 Prolonged-release tablet
EU/1/97/051/032 2.62 milligram(s) N04BC05 Prolonged-release tablet
EU/1/97/051/033 2.62 milligram(s) N04BC05 Prolonged-release tablet
Licence number
EU/1/97/051/031
Strength
2.62 milligram(s)
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet
Licence number
EU/1/97/051/032
Strength
2.62 milligram(s)
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet
Licence number
EU/1/97/051/033
Strength
2.62 milligram(s)
ATC Code
N04BC05
Dosage Form
Prolonged-release tablet

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9

Email
medinfo.ukie@boehringer-ingelheim.com